Clinical Trials Search

Titlesort descending Intervention NCT ID Sponsor Status
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer Surgical Procedure, Laboratory Biomarker Analysis, Nelipepimut-S Plus GM-CSF Vaccine, Sargramostim NCT02636582 National Cancer Institute (NCI) Active, not recruiting
New Assessment System in Measuring Symptom Distress in Cancer Patients Questionnaire Administration, Quality-of-Life Assessment, Interview NCT00505245 M.D. Anderson Cancer Center Recruiting
Nutrition Therapy in Improving Immune System in Patients With Bladder Cancer That Can Be Removed by... Laboratory Biomarker Analysis, Nutritional Intervention, Placebo, Quality-of-Life Assessment, Questionnaire Administration NCT03757949 Southwest Oncology Group Active, not recruiting
Palbociclib and Letrozole or Fulvestrant in Treating Patients With Estrogen Receptor Positive, HER2... Quality-of-Life Assessment, Questionnaire Administration, Fulvestrant, Letrozole, Palbociclib NCT03633331 Alliance for Clinical Trials in Oncology Active, not recruiting
Phase 3 Randomized Placebo Controlled Clinical Trial of Donepezil Donepezil 5 mg, Placebo NCT02822573 Wake Forest University Health Sciences Recruiting
Phase II Study of Isoflavone G-2535 (Genistein) in Patients With Bladder Cancer Genistein, Laboratory Biomarker Analysis, Pharmacological Study, Placebo Administration, Therapeutic Conventional Surgery NCT00118040 National Cancer Institute (NCI) Active, not recruiting
Phase II Study of Metformin for Reduction of Obesity-Associated Breast Cancer Risk Placebo, Metformin NCT02028221 University of Arizona Active, not recruiting
Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery Questionnaire Administration, Z-Endoxifen Hydrochloride, Placebo Administration NCT03317405 National Cancer Institute (NCI) Recruiting
Pilot Study of Denosumab in BRCA1/2 Mutation Carriers Scheduled for Risk-Reducing Salpingo-... Denosumab, Salpingo-Oophorectomy NCT03382574 National Cancer Institute (NCI) Recruiting
Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast... Endocrine therapy interruption NCT02308085 International Breast Cancer Study Group Active, not recruiting